Viral hepatitis: testing saves lives
Every year, around 50 000 newly diagnosed cases of hepatitis B and C are reported across Europe but millions are unaware of their infection. Left untreated, hepatitis can cause irreversible liver damage. Hepatitis A is recognised as a re-emerging health threat in Europe.
ECDC Vaccine Scheduler
The Vaccine Scheduler is an interactive tool that shows vaccination schedules for individual EU/EEA countries and specific age groups. With this tool comparisons can be made for vaccination schedules between two countries or by disease for all or a selection of countries.
- Hepatitis A
- Hepatitis B
- Human papillomavirus infection
- Influenza in humans, seasonal
- Invasive Haemophilus influenzae disease
- Meningococcal disease
- Pneumococcal disease
- Prevention and control
- Rotavirus infection
- Tick-borne diseases
World Hepatitis Day 2018
On the occasion of World Hepatitis Day, ECDC launched online prevalence database for hepatitis B and C which included data mainly based on peer-reviewed cross sectional studies from 2006 onwards.
Assessment of HIV molecular surveillance capacity in the European Union, 2016
Keating, P., Pharris, A., Leitmeyer, K., De Angelis, S., Wensing, A., Amato-Gauci, A.J., Broberg, E.
Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review
Hofstraat, S.H.I., Falla, A.M., Duffell, E.F., Hahné, S.J.M., Amato-Gauci, A.J., Veldhuijzen, I.K., Tavoschi, L.